American Medical Technologies Announces Management Change.

Business Editors/Health & Medical Writers

CORPUS CHRISTI, Texas--(BW HealthWire)--April 24, 2002

American Medical Technologies, Inc. (NASDAQ: ADLI) announced today that Ben Gallant has resigned his position as Chief Executive Officer and has resigned from the Company's Board of Directors. John Vickers, the Company's Chief Operating Officer, was appointed Chairman of the Board and Interim Chief Executive Officer.

John Vickers said, "Ben's innovation skills and entrepreneurial leadership have helped to propel American Medical Technologies to its position of market leadership. We expect to move very quickly to fill the vacuum left by Ben's resignation. The Board anticipates appointing a CEO with proven turnaround experience and credibility in the equity funding arena with a view toward implementing a recapitalization plan."

Mr. Gallant became CEO of American Medical Technologies in September of 1996. Mr. Gallant had previously been CEO and Chairman of the Board of Texas Airsonics, a key supplier to American Medical Technologies, prior to the merger of the two companies in July 1996. Mr. Gallant was the named inventor on many of the patents held by AMT and has contributed substantially to the intellectual property assets of AMT.

Certain statements made in this release may constitute "forward-looking statements" within the meaning of the federal securities laws. While the Company believes that its forward-looking statements are reasonable, you should not place undue reliance on any such forward-looking statements, which speak only as of the date made. These forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond the Company's control or are subject to change, and actual results could be materially different. Factors that might cause such a difference include, without limitation, the lack of availability of a suitable candidate with the requisite experience, the Company's inability to secure the employment of such a candidate and the risks and uncertainties set forth in the Company's periodic reports filed with the Securities and Exchange Commission. Except as required by applicable law, the Company does not undertake any obligation to publicly release any revisions which may be made to any forward-looking statements to reflect events or circumstances occurring after the date of this report.

American Medical Technologies, Inc. headquartered in Corpus Christi, Texas, develops and manufactures advanced technologies for dentistry and markets them worldwide. It is listed on the Nasdaq National Market under the symbol ADLI. Its website is found at www.americandentaltech.com.